{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:46:19Z","timestamp":1792071979243,"version":"4.4.0"},"reference-count":6,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Guangzhou Health Science and Technology Project","award":["20252A011040"],"award-info":[{"award-number":["20252A011040"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province of China","award":["A2025276"],"award-info":[{"award-number":["A2025276"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,10,6]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/jitc-2026-016391","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:00:43Z","timestamp":1792069243000},"page":"e016391","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal and therapeutic confounders in predicting efficacy of immunotherapy rechallenge via baseline intratumoral tertiary lymphoid structures"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-7016","authenticated-orcid":false,"given":"Anran","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Urology, The Third Affiliated Hospital of South China University of Technology, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, Guangdong, China"},{"name":"Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1062-6803","authenticated-orcid":false,"given":"Hongkai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, The Third Affiliated Hospital of South China University of Technology, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7585-8210","authenticated-orcid":false,"given":"Anyang","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Urology, The Third Affiliated Hospital of South China University of Technology, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"2026101506002257000_14.10.e016391.1","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013526","article-title":"Pretreatment intratumoral mature TLSs in non-clear cell renal cell carcinoma are associated with response to immunotherapy rechallenge","volume":"14","author":"Tang","year":"2026","journal-title":"J Immunother Cancer"},{"key":"2026101506002257000_14.10.e016391.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30107-3"},{"key":"2026101506002257000_14.10.e016391.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00290-9"},{"key":"2026101506002257000_14.10.e016391.4","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-017-0273-y","article-title":"Response to single agent PD-1 inhibitor after progression on previous PD-1\/PD-L1 inhibitors: a case series","volume":"5","author":"Martini","year":"2017","journal-title":"J Immunother Cancer"},{"key":"2026101506002257000_14.10.e016391.5","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00345-018-2264-0","article-title":"Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer","volume":"36","author":"Soria","year":"2018","journal-title":"World J Urol"},{"key":"2026101506002257000_14.10.e016391.6","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-016391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:00:44Z","timestamp":1792069244000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-016391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":6,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,15]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/jitc-2026-016391"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-016391","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}